GNRH1 and ovarian hyperstimulation syndrome: The primary clinical application of GnRH agonist triggers is preventing ovarian hyperstimulation syndrome (OHSS), an iatrogenic complication of controlled ovarian stimulation characterized by increased capillary permeability and potential fluid accumulation [6, 7].